Odanacatib is a compound that acts as a selective inhibitor of cathepsin K. It was developed as a pharmaceutical raw material for research into osteoporosis, advancing to late-stage clinical trials before development was discontinued.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Odanacatib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Leucovorin calcium pentahydrate
pharmaceutical raw material
6-Hydroxy-3-(propan-2-yl)-2λ⁶,1,3-benzothiadiazine-2,2,4(1H,3H)-trione
pharmaceutical raw material
Oxazepam
pharmaceutical raw material
Desglymidodrine hydrochloride
pharmaceutical raw material
The international HS code for Odanacatib (CAS 603139-19-1) is 2930.90.
2930.90
2930 90 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide
FWIVDMJALNEADT-SFTDATJTSA-N
CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F
Sourcing Odanacatib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.